InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by KAWAS LEEN. Officer active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €3k. History available since 31 October 2023. The latest transaction was filed on 31 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration